Literature DB >> 6110875

Polymyositis: remarkable response to total body irradiation.

W K Engel, A S Lichter, A P Galdi.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 6110875     DOI: 10.1016/s0140-6736(81)91567-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  The idiopathic inflammatory myopathies and their treatment.

Authors:  J Walton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

Review 2.  Treatment of severe rheumatoid arthritis.

Authors:  V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

Review 3.  Treatment of inflammatory myopathies.

Authors:  A C Cordeiro; D A Isenberg
Journal:  Postgrad Med J       Date:  2006-07       Impact factor: 2.401

Review 4.  Recognition and management of myositis.

Authors:  P Cherin
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

5.  Indications for intravenous gammaglobulin therapy in inflammatory myopathies.

Authors:  P Cherin; S Herson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 6.  Recent advances in polymyositis.

Authors:  W M Behan; P O Behan
Journal:  Ital J Neurol Sci       Date:  1984-03

7.  Intractable polymyositis: prolonged remission induced by total body irradiation.

Authors:  S H Morgan; R M Bernstein; G R Hughes
Journal:  J R Soc Med       Date:  1985-06       Impact factor: 5.344

Review 8.  The inflammatory myopathies.

Authors:  J Walton
Journal:  J R Soc Med       Date:  1983-12       Impact factor: 5.344

9.  Remission from polymyositis after total body irradiation.

Authors:  W N Hubbard; M J Walport; K E Halnan; R P Beaney; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-26

10.  High-dose intravenous human immunoglobulin in polymyositis resistant to treatment.

Authors:  S Jann; S Beretta; M Moggio; L Adobbati; G Pellegrini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.